1. Home
  2. Healthcare
  3. US Structural Heart Devices Market - Size, Share, Segmentation, Regional Insights, Key Players & Forecast, 2026–2035
Sections

Market Outlook

Description

The US Structural Heart Devices Market was valued at approximately USD 7.42 billion in 2025, with historical analysis from 2021 to 2024. The market is projected to reach nearly USD 17.96 billion by 2035, expanding at a CAGR of 9.27% during the forecast period 2026–2035.

Structural heart disease (SHD) treatment in the United States has undergone a paradigm shift over the past decade, transitioning from open-heart surgical procedures to minimally invasive transcatheter interventions. The widespread adoption of transcatheter aortic valve replacement (TAVR), mitral repair systems, and left atrial appendage closure devices has significantly expanded treatment eligibility, especially among elderly and high-risk patients.

The US remains the largest global market for structural heart devices due to advanced cardiac centers, high cardiovascular disease burden, favorable Medicare reimbursement, and strong FDA regulatory frameworks. As the population ages and life expectancy increases, the incidence of degenerative valve disease, atrial fibrillation, and congenital structural abnormalities continues to rise, driving sustained demand.

By 2035, structural heart interventions will increasingly move toward outpatient settings, supported by procedural advancements, device miniaturization, and improved long-term clinical data.

Brief Description
Description

Introduction

According to the US Structural Heart Devices Market Report, the sector is shaped by clinical innovation, regulatory acceleration, and reimbursement-driven expansion. Structural heart disease encompasses defects or abnormalities in heart valves, septa, and associated cardiac structures. In the US, over 2.5 million individuals suffer from aortic stenosis, and millions more experience mitral regurgitation or atrial septal defects.

Historically, open-heart surgery dominated treatment approaches. However, advancements in catheter-based interventions now enable physicians to treat complex structural defects through minimally invasive procedures. The FDA’s progressive approval of TAVR for low-risk patients significantly expanded the eligible population base.

The US healthcare ecosystem—characterized by leading cardiac hospitals, academic research institutions, and device innovation clusters—continues to accelerate the commercialization of next-generation structural heart technologies.


Key Market Drivers: What’s Fueling the US Structural Heart Devices Market Boom?

  • Aging Population & Degenerative Valve Disease
    The US population aged 65 and above is projected to exceed 80 million by 2040. Aortic stenosis prevalence increases sharply with age, making structural valve replacement devices essential in geriatric cardiology.
  • Expansion of TAVR Indications
    The FDA approval of TAVR for low-risk surgical patients expanded procedural volume dramatically. TAVR procedures in the US now exceed surgical aortic valve replacements annually, marking a structural shift in treatment paradigms.
  • Rising Prevalence of Atrial Fibrillation
    Over 6 million Americans live with atrial fibrillation. Left atrial appendage closure devices are increasingly used to prevent stroke in patients unable to tolerate long-term anticoagulation therapy.
  • Favorable Medicare Reimbursement
    CMS coverage policies support TAVR, TMVR, and LAA closure procedures under national coverage determinations, improving hospital adoption rates.
  • Innovation in Transcatheter Technologies
    Advancements in device design, smaller delivery systems, and improved hemodynamic performance enhance procedural safety and long-term durability.

 

Innovation in Focus: How Manufacturers Are Raising the Bar?

Structural heart device manufacturers are investing in next-generation transcatheter valves with enhanced leaflet durability and repositionable deployment systems. Companies are integrating imaging guidance compatibility to improve procedural precision.

Mitral repair technologies now incorporate chordal replacement systems and percutaneous edge-to-edge repair devices. In addition, companies are exploring transcatheter tricuspid valve therapies—an emerging frontier in structural heart interventions.

Clinical trials in the US are evaluating expanded indications, long-term outcomes, and valve durability beyond 10 years, ensuring sustainable market growth.


Recent Developments

Recent US market developments include expanded TAVR approvals for low-risk patients, increasing LAA closure procedure volumes, and clinical trials for transcatheter tricuspid valve therapies. Hospitals are investing heavily in hybrid operating rooms and structural heart centers of excellence.


Conclusion

The US Structural Heart Devices Market Size & Share continues to grow steadily as minimally invasive cardiac interventions replace traditional surgical procedures. With strong reimbursement frameworks, aging demographics, technological advancements, and expanding clinical evidence, the US structural heart devices sector remains positioned for long-term expansion through 2035.

Key Market Players

Description

The US Structural Heart Devices Competitive Landscape is moderately consolidated, dominated by multinational cardiovascular device manufacturers.

  • Edwards Lifesciences
  • Medtronic
  • Abbott Laboratories
  • Boston Scientific
  • Terumo Corporation
  • LivaNova
  • JenaValve Technology
  • CryoLife
  • Atricure
  • Biotronik
  • Lepu Medical
  • MicroPort Scientific
  • Venus MedTech
  • Cardiovalve
  • NeoChord
  • Ancora Heart
  • HighLife SAS
  • Mitralign
  • Transseptal Solutions
  • Artivion
  • Corcym
  • W. L. Gore & Associates
  • B. Braun
  • Cook Medical
  • Meril Life Sciences
Segmentation By Product Type
Description
  • Transcatheter Heart Valves – Dominant Segment
    Includes TAVR and transcatheter mitral valve systems. TAVR dominates revenue due to widespread clinical adoption.
  • Occluders & Closure Devices
    Used for atrial septal defect (ASD) and patent foramen ovale (PFO) closure. Pediatric and adult congenital cardiology programs drive demand.
  • Annuloplasty Rings
    Primarily used in surgical mitral valve repair procedures.
  • Left Atrial Appendage (LAA) Closure Devices – Fastest Growing
    Growing adoption for stroke prevention in AFib patients unsuitable for anticoagulation.
  • Paravalvular Leak Repair Devices
    Specialized devices addressing post-valve replacement complications.
Segmentation By Procedure Type
Description
  • Transcatheter Aortic Valve Replacement (TAVR) – Largest Segment
    Represents the majority of structural heart interventions in the US.
  • Transcatheter Mitral Valve Repair (TMVR)
    Includes edge-to-edge repair and emerging replacement systems.
  • Surgical Valve Replacement
    Still relevant for younger patients requiring durable solutions.
  • Septal Defect Closure
    Common in congenital cardiology programs.
  • LAA Closure Procedures – Fastest Growing
    Rapid increase due to expanding AFib screening programs.
Segmentation By Indication
Description
  • Aortic Stenosis – Dominant
    High prevalence among elderly patients.
  • Mitral Regurgitation
    Second largest indication.
  • Congenital Heart Defects
    Includes ASD and ventricular septal defect closures.
  • Atrial Fibrillation
    Drives LAA closure demand.
  • Structural Valve Degeneration
    Growing need for valve-in-valve procedures.
Segmentation By End User
Description
  • Hospitals – Dominant
    Tertiary care centers perform the majority of TAVR and TMVR procedures.
  • Cardiac Catheterization Laboratories
    Expansion of structural heart programs into dedicated cath labs.
  • Ambulatory Surgical Centers – Emerging
    Select structural interventions moving toward outpatient settings.
  • Specialty Cardiac Centers
    High-volume structural heart programs in academic institutions.
Segmentation By States
Description
  • West Region – Market Leader
    California leads national TAVR volume due to large hospital networks and aging demographics. Washington and Colorado benefit from advanced cardiac research institutions. Arizona sees high structural heart intervention demand due to retiree population. Oregon and other states including Nevada, Utah, New Mexico, Idaho, Montana, Wyoming, Alaska, and Hawaii are expanding structural heart access programs.
  • Northeast Region – Innovation & Academic Hub
    New York and Massachusetts host leading academic heart centers driving clinical trials. New Jersey, Pennsylvania, and Connecticut demonstrate high TAVR penetration. Smaller states including Maine, Vermont, New Hampshire, Rhode Island, and Delaware increasingly refer complex cases to regional centers.
  • South Region – Fastest Growing
    Texas and Florida lead in procedure volumes due to population size and high cardiovascular prevalence. Georgia and North Carolina are expanding structural heart programs. Tennessee, South Carolina, Alabama, and others including Mississippi, Louisiana, Arkansas, Kentucky, Oklahoma, Virginia, Maryland, and West Virginia show rapid hospital modernization.
  • Midwest Region – Stable Growth
    Illinois and Ohio lead regional volumes. Michigan and Minnesota benefit from strong cardiac centers. Indiana, Wisconsin, Missouri, and others including Iowa, Kansas, Nebraska, North Dakota, and South Dakota are steadily expanding structural heart programs.
Table of Contents
Description

1. US Structural Heart Devices Market: Market Introduction & Context
1.1 Market Definition
1.2 Scope of the Study
1.3 Research Methodology
1.3.1 Primary Data Collection
1.3.2 Secondary Data Sourcing
1.3.3 External Industry Collaborations
1.3.4 In-House Research Databases
1.3.5 Analytical Frameworks & Forecasting Models
1.3.6 Data Validation and Final Report Publishing
1.4 Key Assumptions
1.5 Market Ecosystem Overview
1.6 Stakeholder Analysis
1.6.1 Device Manufacturers
1.6.2 Component Suppliers
1.6.3 Cardiac Centers & Hospitals
1.6.4 Distributors
1.6.5 Regulatory Authorities
1.6.6 Payers & Reimbursement Bodies

(What this section provides: Introduces the scope, research framework, assumptions, and ecosystem mapping to establish credibility and analytical transparency.)

2. US Structural Heart Devices Market: Executive Summary
2.1 Key Insights & Market Snapshot
2.2 Analyst Viewpoint
2.3 Market Attractiveness Index

(What this section provides: Summarizes market valuation, CAGR (2026–2035), leading segments, competitive landscape, and growth outlook.)

3. US Structural Heart Devices Market: Market Dynamics & Outlook
3.1 Drivers and Their Impact Analysis
3.2 Restraints and Their Impact Analysis
3.3 Opportunities and Their Impact Analysis
3.4 Emerging Therapies & Expanded Indications
3.5 Patent & Innovation Analysis (2020–2025)

(What this section provides: Evaluates key growth catalysts, technological advancements, reimbursement evolution, and regulatory influences shaping market expansion.)

4. US Structural Heart Devices Market: Market Environment & Industry Analysis
4.1 PESTEL Analysis
4.1.1 Political
4.1.2 Economic
4.1.3 Social
4.1.4 Technological
4.1.5 Environmental
4.1.6 Legal
4.2 Porter’s Five Forces Analysis
4.2.1 Threat of New Entrants
4.2.2 Bargaining Power of Buyers
4.2.3 Bargaining Power of Suppliers
4.2.4 Substitution Risk
4.2.5 Competitive Rivalry
4.3 Pricing Trend Analysis by Region (2024–2030)
4.4 Value Chain & Supply Chain Analysis
4.5 Impact of Digitalization & Imaging Integration
4.6 Application & Innovation Landscape
4.7 Regulatory Framework Analysis (FDA & CMS)
4.8 Import/Export Restrictions & Tariff Impact
4.9 Government Initiatives & Reimbursement Policies
4.10 Impact of Escalating Geopolitical Tensions

(What this section provides: Provides a comprehensive industry-level evaluation including regulatory frameworks, pricing structures, competition intensity, and macroeconomic factors.)

5. US Structural Heart Devices Market – By Product Type
5.1 Overview
5.2 Segment Share Analysis, By Product Type, 2025 & 2035 (%)
5.3 Transcatheter Heart Valves
5.4 Occluders & Closure Devices
5.5 Annuloplasty Rings
5.6 Left Atrial Appendage (LAA) Closure Devices
5.7 Paravalvular Leak Repair Devices

(What this section provides: Examines revenue distribution, clinical adoption trends, and innovation developments across structural heart product categories.)

6. US Structural Heart Devices Market – By Procedure Type
6.1 Overview
6.2 Segment Share Analysis, By Procedure Type, 2025 & 2035 (%)
6.3 Transcatheter Aortic Valve Replacement (TAVR)
6.4 Transcatheter Mitral Valve Repair (TMVR)
6.5 Surgical Valve Replacement
6.6 Septal Defect Closure Procedures
6.7 Left Atrial Appendage Closure Procedures

(What this section provides: Analyzes procedure volumes, hospital penetration, and shifting intervention preferences.)

7. US Structural Heart Devices Market – By Indication
7.1 Overview
7.2 Segment Share Analysis, By Indication, 2025 & 2035 (%)
7.3 Aortic Stenosis
7.4 Mitral Regurgitation
7.5 Congenital Heart Defects
7.6 Atrial Fibrillation
7.7 Structural Valve Degeneration

(What this section provides: Highlights disease prevalence trends driving structural heart intervention demand.)

8. US Structural Heart Devices Market – By End-User
8.1 Overview
8.2 Segment Share Analysis, By End-User, 2025 & 2035 (%)
8.3 Hospitals
8.4 Cardiac Catheterization Laboratories
8.5 Ambulatory Surgical Centers
8.6 Specialty Cardiac Centers

(What this section provides: Identifies key demand centers and evolving care delivery models.)

9. US Structural Heart Devices Market – By Geography
9.1 Introduction
9.2 Segment Share Analysis, By Geography, 2025 & 2035 (%)
9.3 West Region
9.3.1 Regional Overview & Trends
9.3.2 Key Manufacturers in West Region
9.3.3 Market Size & Forecast, By State, 2025–2035 (US$ Million)
9.3.4 California
9.3.5 Washington
9.3.6 Colorado
9.3.7 Arizona
9.3.8 Oregon
9.3.9 Utah
9.3.10 Nevada
9.3.11 New Mexico
9.3.12 Idaho
9.3.13 Montana
9.3.14 Wyoming
9.3.15 Alaska
9.3.16 Hawaii
9.4 Northeast Region
9.4.1 Regional Overview & Trends
9.4.2 New York
9.4.3 Massachusetts
9.4.4 New Jersey
9.4.5 Pennsylvania
9.4.6 Connecticut
9.4.7 Maine
9.4.8 Vermont
9.4.9 New Hampshire
9.4.10 Rhode Island
9.4.11 Delaware
9.5 South Region
9.5.1 Regional Overview & Trends
9.5.2 Texas
9.5.3 Florida
9.5.4 Georgia
9.5.5 North Carolina
9.5.6 Tennessee
9.5.7 South Carolina
9.5.8 Alabama
9.5.9 Mississippi
9.5.10 Louisiana
9.5.11 Arkansas
9.5.12 Kentucky
9.5.13 Oklahoma
9.5.14 Maryland
9.5.15 Virginia
9.5.16 West Virginia
9.6 Midwest Region
9.6.1 Regional Overview & Trends
9.6.2 Illinois
9.6.3 Ohio
9.6.4 Michigan
9.6.5 Minnesota
9.6.6 Indiana
9.6.7 Wisconsin
9.6.8 Missouri
9.6.9 Iowa
9.6.10 Kansas
9.6.11 Nebraska
9.6.12 North Dakota
9.6.13 South Dakota

(What this section provides: Provides comprehensive state-level revenue forecasts, procedural volume insights, demographic trends, reimbursement penetration, and regional competitive mapping.)

10. US Structural Heart Devices Market: Competitive Landscape & Company Profiles
10.1 Market Share Analysis (2025)
10.2 Company Positioning Matrix
10.3 Company Profiles
10.3.1 Edwards Lifesciences
10.3.2 Medtronic
10.3.3 Abbott Laboratories
10.3.4 Boston Scientific
10.3.5 Terumo Corporation
10.3.6 LivaNova
10.3.7 JenaValve Technology
10.3.8 CryoLife (Artivion)
10.3.9 AtriCure
10.3.10 Biotronik
10.3.11 MicroPort Scientific
10.3.12 Venus MedTech
10.3.13 Cardiovalve
10.3.14 NeoChord
10.3.15 Ancora Heart
10.3.16 HighLife SAS
10.3.17 Mitralign
10.3.18 Transseptal Solutions
10.3.19 Corcym
10.3.20 W. L. Gore & Associates
10.3.21 B. Braun
10.3.22 Cook Medical
10.3.23 Meril Life Sciences
10.3.24 Lepu Medical
10.3.25 Artivion

(What this section provides: Benchmarks key players, market shares, competitive strategies, product portfolios, and innovation positioning.)

11. US Structural Heart Devices Market: Future Market Outlook (2025–2035)
11.1 Scenario Analysis (Optimistic, Realistic, Pessimistic)
11.2 Disruptive Technologies Impact
11.3 Emerging Business Trends
11.4 Business Opportunities for Startups & Established Players

(What this section provides: Projects long-term market evolution, innovation impact, and investment outlook.)

12. US Structural Heart Devices Market: Strategic Recommendations

(What this section provides: Offers actionable strategic guidance for manufacturers, healthcare providers, investors, and policymakers.)

13. US Structural Heart Devices Market: Disclaimer

(What this section provides: Defines legal limitations, research boundaries, assumptions, and terms of use.)

Tables and Figures
Description

List of Tables

TABLE 1: List of Data Sources
TABLE 2: Market Drivers; Impact Analysis
TABLE 3: Market Restraints; Impact Analysis
TABLE 4: US Structural Heart Devices Market: Product Type Snapshot (2025)
TABLE 5: Segment Dashboard; Definition and Scope, by Product Type
TABLE 6: US Structural Heart Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 7: US Structural Heart Devices Market: Procedure Type Snapshot (2025)
TABLE 8: Segment Dashboard; Definition and Scope, by Procedure Type
TABLE 9: US Structural Heart Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 10: US Structural Heart Devices Market: Indication Snapshot (2025)
TABLE 11: Segment Dashboard; Definition and Scope, by Indication
TABLE 12: US Structural Heart Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 13: US Structural Heart Devices Market: End-User Snapshot (2025)
TABLE 14: Segment Dashboard; Definition and Scope, by End-User
TABLE 15: US Structural Heart Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 16: US Structural Heart Devices Market: Regional Snapshot (2025)
TABLE 17: Segment Dashboard; Definition and Scope, by Region
TABLE 18: US Structural Heart Devices Market, by Region, 2022–2035 (USD Million)
TABLE 19: California Structural Heart Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 20: California Structural Heart Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 21: California Structural Heart Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 22: California Structural Heart Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 23: Washington Structural Heart Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 24: Washington Structural Heart Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 25: Washington Structural Heart Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 26: Washington Structural Heart Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 27: Colorado Structural Heart Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 28: Colorado Structural Heart Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 29: Colorado Structural Heart Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 30: Colorado Structural Heart Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 31: Arizona Structural Heart Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 32: Arizona Structural Heart Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 33: Arizona Structural Heart Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 34: Arizona Structural Heart Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 35: Oregon Structural Heart Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 36: Oregon Structural Heart Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 37: Oregon Structural Heart Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 38: Oregon Structural Heart Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 39: West – Others Structural Heart Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 40: West – Others Structural Heart Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 41: West – Others Structural Heart Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 42: West – Others Structural Heart Devices Market, by End-User, 2022–2035 (USD Million)
(Nevada, Utah, New Mexico, Idaho, Montana, Wyoming, Alaska, Hawaii)
TABLE 43: New York Structural Heart Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 44: New York Structural Heart Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 45: New York Structural Heart Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 46: New York Structural Heart Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 47: Massachusetts Structural Heart Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 48: Massachusetts Structural Heart Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 49: Massachusetts Structural Heart Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 50: Massachusetts Structural Heart Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 51: New Jersey Structural Heart Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 52: New Jersey Structural Heart Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 53: New Jersey Structural Heart Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 54: New Jersey Structural Heart Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 55: Pennsylvania Structural Heart Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 56: Pennsylvania Structural Heart Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 57: Pennsylvania Structural Heart Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 58: Pennsylvania Structural Heart Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 59: Connecticut Structural Heart Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 60: Connecticut Structural Heart Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 61: Connecticut Structural Heart Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 62: Connecticut Structural Heart Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 63: Northeast – Others Structural Heart Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 64: Northeast – Others Structural Heart Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 65: Northeast – Others Structural Heart Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 66: Northeast – Others Structural Heart Devices Market, by End-User, 2022–2035 (USD Million)
(Maine, Vermont, New Hampshire, Rhode Island, Delaware)
TABLE 67: Texas Structural Heart Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 68: Texas Structural Heart Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 69: Texas Structural Heart Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 70: Texas Structural Heart Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 71: Florida Structural Heart Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 72: Florida Structural Heart Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 73: Florida Structural Heart Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 74: Florida Structural Heart Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 75: Georgia Structural Heart Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 76: Georgia Structural Heart Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 77: Georgia Structural Heart Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 78: Georgia Structural Heart Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 79: North Carolina Structural Heart Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 80: North Carolina Structural Heart Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 81: North Carolina Structural Heart Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 82: North Carolina Structural Heart Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 83: Tennessee Structural Heart Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 84: Tennessee Structural Heart Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 85: Tennessee Structural Heart Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 86: Tennessee Structural Heart Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 87: South Carolina Structural Heart Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 88: South Carolina Structural Heart Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 89: South Carolina Structural Heart Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 90: South Carolina Structural Heart Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 91: Alabama Structural Heart Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 92: Alabama Structural Heart Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 93: Alabama Structural Heart Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 94: Alabama Structural Heart Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 95: South – Others Structural Heart Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 96: South – Others Structural Heart Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 97: South – Others Structural Heart Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 98: South – Others Structural Heart Devices Market, by End-User, 2022–2035 (USD Million)
(Mississippi, Louisiana, Arkansas, Kentucky, Oklahoma, Maryland, Virginia, West Virginia)
TABLE 99: Illinois Structural Heart Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 100: Illinois Structural Heart Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 101: Illinois Structural Heart Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 102: Illinois Structural Heart Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 103: Ohio Structural Heart Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 104: Ohio Structural Heart Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 105: Ohio Structural Heart Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 106: Ohio Structural Heart Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 107: Michigan Structural Heart Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 108: Michigan Structural Heart Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 109: Michigan Structural Heart Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 110: Michigan Structural Heart Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 111: Minnesota Structural Heart Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 112: Minnesota Structural Heart Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 113: Minnesota Structural Heart Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 114: Minnesota Structural Heart Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 115: Indiana Structural Heart Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 116: Indiana Structural Heart Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 117: Indiana Structural Heart Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 118: Indiana Structural Heart Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 119: Wisconsin Structural Heart Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 120: Wisconsin Structural Heart Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 121: Wisconsin Structural Heart Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 122: Wisconsin Structural Heart Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 123: Missouri Structural Heart Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 124: Missouri Structural Heart Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 125: Missouri Structural Heart Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 126: Missouri Structural Heart Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 127: Midwest – Others Structural Heart Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 128: Midwest – Others Structural Heart Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 129: Midwest – Others Structural Heart Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 130: Midwest – Others Structural Heart Devices Market, by End-User, 2022–2035 (USD Million)
(Iowa, Kansas, Nebraska, North Dakota, South Dakota)

List of Figures

FIGURE 1: US Structural Heart Devices Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Value Chain Analysis
FIGURE 4: PESTEL Analysis
FIGURE 5: Porter’s Five Forces Analysis
FIGURE 6: Market Attractiveness Analysis
FIGURE 7: Market Dynamics
FIGURE 8: Innovation & Patent Landscape (2020–2024)
FIGURE 9: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 10: Product Type Segment Market Share Analysis, 2025 & 2035
FIGURE 11: Product Type Segment Market Size Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 12: Procedure Type Segment Market Share Analysis, 2025 & 2035
FIGURE 13: Procedure Type Segment Market Size Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 14: Indication Segment Market Share Analysis, 2025 & 2035
FIGURE 15: Indication Segment Market Size Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 16: End-User Segment Market Share Analysis, 2025 & 2035
FIGURE 17: End-User Segment Market Size Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 18: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 19: Regional Segment Market Size Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 20: West Region Structural Heart Devices Market Share and Leading Players, 2025
FIGURE 21: Northeast Region Structural Heart Devices Market Share and Leading Players, 2025
FIGURE 22: South Region Structural Heart Devices Market Share and Leading Players, 2025
FIGURE 23: Midwest Region Structural Heart Devices Market Share and Leading Players, 2025
FIGURE 24: West Region Market Share Analysis by State, 2025
FIGURE 25: California Structural Heart Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 26: Washington Structural Heart Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 27: Colorado Structural Heart Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 28: Arizona Structural Heart Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 29: Oregon Structural Heart Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 30: Others (West Region) Structural Heart Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 31: South Region Market Share Analysis by State, 2025
FIGURE 32: Texas Structural Heart Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 33: Florida Structural Heart Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 34: Georgia Structural Heart Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 35: North Carolina Structural Heart Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 36: Tennessee Structural Heart Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 37: South Carolina Structural Heart Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 38: Alabama Structural Heart Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 39: Others (South Region) Structural Heart Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 40: Midwest Region Market Share Analysis by State, 2025
FIGURE 41: Illinois Structural Heart Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 42: Ohio Structural Heart Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 43: Michigan Structural Heart Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 44: Minnesota Structural Heart Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 45: Indiana Structural Heart Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 46: Wisconsin Structural Heart Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 47: Missouri Structural Heart Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 48: Others (Midwest Region) Structural Heart Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 49: Northeast Region Market Share Analysis by State, 2025
FIGURE 50: New York Structural Heart Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 51: Massachusetts Structural Heart Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 52: New Jersey Structural Heart Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 53: Pennsylvania Structural Heart Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 54: Connecticut Structural Heart Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 55: Others (Northeast Region) Structural Heart Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)

Research Methodology

Market Research Methodology for Quants and Trends